MAGE-4 (143-151)

MAGE-4 (143-151) is a synthetic peptide fragment derived from the melanoma-associated antigen 4 (MAGE-4) protein, specifically encompassing amino acid residues 143 to 151. As a member of the MAGE family of cancer-testis antigens, this peptide is of considerable interest in immunological research, particularly in the context of tumor antigenicity, T-cell epitope mapping, and the study of antigen processing and presentation. Its defined sequence and immunogenic properties make it a valuable tool for exploring the molecular mechanisms underlying cellular immune responses to tumor-associated antigens.

Epitope mapping: Researchers utilize the 143-151 fragment of MAGE-4 to identify and characterize T-cell epitopes that are recognized by cytotoxic T lymphocytes (CTLs). By employing this peptide in various immunological assays, including ELISPOT and intracellular cytokine staining, investigators can determine the specificity and functional avidity of CTLs targeting MAGE-4-expressing tumors. This approach facilitates a deeper understanding of antigenic determinants involved in anti-tumor immunity and supports the rational design of immunotherapeutic strategies.

Antigen processing studies: The defined sequence of this peptide enables its use as a model substrate in studies of antigen processing and presentation by major histocompatibility complex (MHC) class I molecules. By tracking the cellular handling of exogenously supplied peptides, scientists can elucidate pathways of peptide loading, transport, and MHC-peptide complex stability, providing insight into the mechanisms that govern immune recognition of tumor cells.

Peptide-MHC binding assays: The MAGE-4 (143-151) peptide serves as a reference ligand in quantitative binding assays designed to assess the affinity and stability of peptide-MHC class I complexes. These studies are pivotal for understanding the molecular interactions that dictate epitope presentation and for evaluating the immunogenic potential of tumor-associated peptides. Such assays inform the selection and optimization of peptide candidates for further immunological investigation.

Functional T-cell activation: In vitro stimulation of peripheral blood mononuclear cells (PBMCs) or isolated T-cell populations with this peptide enables assessment of antigen-specific activation, cytokine production, and cytotoxic activity. This application is central to dissecting the functional properties of T-cell responses against MAGE-4-expressing malignancies and supports the evaluation of T-cell receptor (TCR) specificity and efficacy in preclinical immunology research.

Peptide-based assay development: The well-defined structure and immunological relevance of MAGE-4 (143-151) make it suitable for incorporation into custom assay platforms, such as peptide microarrays or multiplexed immunoassays. Through these platforms, the peptide can be used to screen for the presence of antigen-specific T cells, evaluate immune monitoring protocols, or validate new assay methodologies. This versatility supports a broad range of investigative and quality control applications in immunological and oncological research.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle